• Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

    Recruiting

    2 1
    Investigated diseases:
    Belgium Bulgaria Croatia Czechia Germany Italy +2

  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Greece Norway Spain

  • Study of methadone and morphine combination for pain relief in patients with bone metastases from cancer

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of DBV712 skin patch safety in children aged 1-3 years with peanut allergy

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Ireland The Netherlands Spain

  • Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated drugs:
    Croatia Czechia Germany Greece Italy Poland +2

  • Study of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)

    Recruiting

    2 1 1
    Investigated drugs:
    Greece

  • Study of depemokimab to improve airway function in patients with type 2 eosinophilic asthma

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Italy Spain

  • Study of daratumumab, teclistamab and talquetamab combination treatment for frail patients with newly diagnosed multiple myeloma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy The Netherlands Norway Spain

  • Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia Finland France Germany +8

  • Study of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

powered by